← All organizations

Themis Bioscience GmbH

For profitWebsite ↗

Also known as: Themis Bioscience GmbH

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Aug 10, 2020

Acquired by Merck on May 26, 2020

Timeline

2000s

Sep 1, 2009
Themis Bioscience GmbH— Founded

2020s

May 26, 2020
Merck— Acquired By

Drugs by trial phase (11 distinct, 9 trials)

Phase 2 (7 own, 0 via acquisition)

Phase 1 (4 own, 0 via acquisition)

Indications

Studied for

Recent trials (9)

NCT04497298CollaboratorPhase 1Aug 10, 2020
NCT04195373Lead sponsorPhase 1/Phase 2Apr 30, 2020
NCT04055454Lead sponsorPhase 1Sep 30, 2019
NCT04033068Lead sponsorPhase 1Aug 1, 2019
NCT03807843Lead sponsorPhase 2Mar 4, 2019
NCT03635086Lead sponsorPhase 2Sep 17, 2018
NCT03101111Lead sponsorPhase 2May 24, 2017
NCT02996890Lead sponsorPhase 1Apr 4, 2017
NCT02861586Lead sponsorPhase 2Aug 1, 2016

Details

Founded: Vienna, AT Sep 1, 2009
Last known activity: Aug 10, 2020